Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Healthy Volunteers)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05216510
What this trial is testing

Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens

Who this might be right for
Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2
Tonix Pharmaceuticals, Inc. 9
Early research (Phase 1)UnknownNCT05453279
What this trial is testing

A Dose Escalation Phase 1 Study Evaluating the Safety and Pharmacokinetics of an Inhaled COVID-19 Inhibitor Delcetravir in Healthy Subjects

Who this might be right for
COVID-19
Esfam Biotech Pty Ltd 8
Early research (Phase 1)Study completedNCT04523571
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects

Who this might be right for
SARS-CoV-2
BioNTech SE 144
Early research (Phase 1)Study completedNCT05840952
What this trial is testing

A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

Who this might be right for
COVID-19
Aligos Therapeutics 90
Testing effectiveness (Phase 2)Study completedNCT04824638
What this trial is testing

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers

Who this might be right for
HealthyImmunization; Infection
ANRS, Emerging Infectious Diseases 267
Not applicableUnknownNCT04547114
What this trial is testing

Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects

Who this might be right for
SARS-CoV-2 Infection
Klinikum Bayreuth GmbH 200
Early research (Phase 1)Study completedNCT05005312
What this trial is testing

Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332

Who this might be right for
Hepatic Impairment
Pfizer 17
Testing effectiveness (Phase 2)Study completedNCT04962893
What this trial is testing

Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine

Who this might be right for
Covid19
Ihsan GURSEL, PhD, Prof. 349
Early research (Phase 1)UnknownNCT04838080
What this trial is testing

Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo

Who this might be right for
COVID-19 Vaccine
Kocak Farma 38
Early research (Phase 1)Ended earlyNCT04627675
What this trial is testing

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)

Who this might be right for
SARS-CoV-2
Providence Health & Services 16
Testing effectiveness (Phase 2)Study completedNCT05142553
What this trial is testing

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 887
Testing effectiveness (Phase 2)Study completedNCT04447781
What this trial is testing

Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19

Who this might be right for
Coronavirus InfectionSARS-CoV 2
International Vaccine Institute 79
Testing effectiveness (Phase 2)UnknownNCT05409300
What this trial is testing

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Who this might be right for
COVID-19Vaccine Adverse ReactionSars-CoV-2 Infection+1 more
ANRS, Emerging Infectious Diseases 200
Early research (Phase 1)Study completedNCT05293249
What this trial is testing

DMAbs for Prevention of COVID-19

Who this might be right for
Healthy Volunteers
Pablo Tebas 61
Not applicableStudy completedNCT05668104
What this trial is testing

Jing Si Herbal Tea for Long-Coronavirus Disease(COVID) Gut-brain Interaction

Who this might be right for
Healthy SubjectsCOVID-19 PneumoniaIrritable Bowel Syndrome+1 more
Buddhist Tzu Chi General Hospital 32
Early research (Phase 1)Study completedNCT04483375
What this trial is testing

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Who this might be right for
Coronavirus Disease 2019(COVID-19)
Sinocelltech Ltd. 33
Early research (Phase 1)Study completedNCT04576312
What this trial is testing

Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers

Who this might be right for
Covid19
UNION therapeutics 64
Early research (Phase 1)Study completedNCT04392219
What this trial is testing

COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers

Who this might be right for
Coronavirus
Ridgeback Biotherapeutics, LP 130
Early research (Phase 1)Study completedNCT05064800
What this trial is testing

PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants

Who this might be right for
Healthy Participants
Pfizer 24
Testing effectiveness (Phase 2)Study completedNCT05696067
What this trial is testing

Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers

Who this might be right for
COVID-19
Tatyana Zubkova 200
Next Page